🔗 Permalink

Inventor profile of:

Michael Oestergaard

City:

Carlsbad, California

Country:

United States

Published Applications:

Last publication date:

2025-12-11

Top Assignees for applications by Michael Oestergaard

The entities that hold a legal rights for patent applications filed by inventor Oestergaard Michael:

Ionis Pharmaceuticals, Inc. 41 Carlsbad, CA United States
ISIS Pharmaceuticals, Inc. 5 Carlsbad, CA United States
Ionis Pharmaceuticals 1 Carlsbad, CA United States
BicycleTx Limited 1 Cambridge, United Kingdom
The Regents of the University of California 1 Oakland, CA United States
lonis Pharmaceuticals, Inc. 1 Carlsbad, CA United States

Recent patent applications by Oestergaard Michael

Michael Oestergaard from Carlsbad, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-11

US20250376683A1

Chemistry; metallurgy

Selective Antisense Compounds and Uses Thereof

#2 | 2025-12-04

US20250368995A1

Chemistry; metallurgy

Linkage Modified Oligomeric Compounds and Uses Thereof

#3 | 2025-11-20

US20250354135A1

Chemistry; metallurgy

Modified Compounds and Uses Thereof

#4 | 2025-10-30

US20250333741A1

Chemistry; metallurgy

Conjugated Antisense Compounds and Their Use

#5 | 2025-08-28

US20250270554A1

Chemistry; metallurgy

Selective Antisense Compounds and Uses Thereof

#6 | 2025-06-05

US20250177433A1

Human necessities

COMPOUNDS AND METHODS FOR REDUCING DMPK EXPRESSION

#7 | 2025-05-15

US20250154506A1

Chemistry; metallurgy

LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

#8 | 2024-11-21

US20240382605A1

Human necessities

CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF

#9 | 2024-11-07

US20240368592A1

Chemistry; metallurgy

Selective Antisense Compounds and Uses Thereof

#10 | 2024-10-03

US20240325425A1

Human necessities

ALLELE-SELECTIVE COMPOUNDS AND METHODS FOR MODULATING HUNTINGTIN EXPRESSION

#11 | 2024-09-05

US20240294923A1

Chemistry; metallurgy

Selective Antisense Compounds and Uses Thereof

#12 | 2024-09-05

US20240293563A1

Human necessities

GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF

#13 | 2024-08-22

US20240279664A1

Chemistry; metallurgy

Conjugated antisense compounds and their use

#14 | 2024-05-02

US20240141343A1

Chemistry; metallurgy

Selective Antisense Compounds and Uses Thereof

#15 | 2024-01-04

US20240002851A1

Chemistry; metallurgy

LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF

#16 | 2023-04-13

US20230113863A1

Chemistry; metallurgy

Selective Antisense Compounds and Uses Thereof

#17 | 2023-03-02

US20230068063A1

Chemistry; metallurgy

Modified compounds and uses thereof

#18 | 2023-01-05

US20230002763A1

Chemistry; metallurgy

Selective antisense compounds and uses thereof

#19 | 2022-06-16

US20220186222A1

Chemistry; metallurgy

Linkage modified oligomeric compounds and uses thereof

#20 | 2022-01-27

US20220023429A1

Human necessities

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

#21 | 2021-12-09

US20210380976A1

Chemistry; metallurgy

CHIRALLY ENRICHED OLIGOMERIC COMPOUNDS

#22 | 2021-08-26

US20210261945A1

Chemistry; metallurgy

Modified compounds and uses thereof

#23 | 2021-08-05

US20210238591A1

Chemistry; metallurgy

Selective antisense compounds and uses thereof

#24 | 2021-05-20

US20210147838A1

Chemistry; metallurgy

Selective Antisense Compounds and Uses Thereof

#25 | 2021-02-25

US20210052631A1

Human necessities

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

#26 | 2021-01-21

US20210017513A1

Chemistry; metallurgy

Modified compounds and uses thereof

#27 | 2021-01-07

US20210002636A1

Chemistry; metallurgy

Selective antisense compounds and uses thereof

#28 | 2020-12-17

US20200392509A1

Chemistry; metallurgy

Conjugated antisense compounds and their use

#29 | 2020-08-27

US20200268898A1

Human necessities

GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF

#30 | 2020-07-30

US20200239881A1

Chemistry; metallurgy

Morpholino modified oligomeric compounds

#31 | 2020-02-20

US20200056187A1

Chemistry; metallurgy

SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF

#32 | 2019-11-28

US20190359979A1

Chemistry; metallurgy

Oligomeric compounds comprising α-β-constrained nucleic acid

#33 | 2019-09-12

US20190276823A1

Chemistry; metallurgy

SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF

#34 | 2018-10-25

US20180305687A1

Chemistry; metallurgy

Linkage modified oligomeric compounds

#35 | 2018-09-13

US20180256729A1

Human necessities

Conjugated antisense compounds and their use

#36 | 2018-01-11

US20180010126A1

Chemistry; metallurgy

ANTISENSE COMPOUNDS AND USES THEREOF

#37 | 2017-11-16

US20170327824A1

Chemistry; metallurgy

SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF

#38 | 2017-02-16

US20170044539A1

Chemistry; metallurgy

Oligomeric compounds comprising alpha-beta-constrained nucleic acid

#39 | 2017-02-16

US20170044526A1

Chemistry; metallurgy

Linkage modified oligomeric compounds

#40 | 2016-03-31

US20160090598A1

Chemistry; metallurgy

Antisense compounds and uses thereof

#41 | 2015-12-31

US20150376625A1

Chemistry; metallurgy

Selective antisense compounds and uses thereof

#42 | 2015-10-01

US20150275208A1

Chemistry; metallurgy

SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF

#43 | 2014-10-30

US20140323707A1

Chemistry; metallurgy

Selective antisense compounds and uses thereof

#44 | 2014-10-16

US20140309279A1

Chemistry; metallurgy

Gapped oligomeric compounds comprising 5′-modified deoxyribonucleosides in the gap and uses thereof

#45 | 2014-10-09

US20140303235A1

Chemistry; metallurgy

LINKAGE MODIFIED GAPPED OLIGOMERIC COMPOUNDS AND USES THEREOF

InventorID:

930990 ⎘